A Safety Study of SGN-2FF for Patients With Advanced Solid Tumors

Conditions:   Non-small Cell Lung Cancer;   Renal Cell Cancer;   Breast Cancer;   Bladder Cancer;   Head and Neck Cancer;   Colorectal Cancer
Intervention:   Drug: SGN-2FF
Sponsor:   Seattle Genetics, Inc.
Not yet recruiting - verified October 2016

http://ift.tt/2femyLd